Cenicriviroc Enrolling by Invitation Phase 2 Trials for Non-Alcoholic Fatty Liver Disease (NAFLD) / Liver Cirrhosis / Nonalcoholic Steatohepatitis Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03059446Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis